{"id":3691,"date":"2023-05-30T13:10:16","date_gmt":"2023-05-30T18:10:16","guid":{"rendered":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/?p=3691"},"modified":"2023-05-30T13:10:19","modified_gmt":"2023-05-30T18:10:19","slug":"neurologic-events-after-covid-19-vaccines-assessed","status":"publish","type":"post","link":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/2023\/05\/30\/neurologic-events-after-covid-19-vaccines-assessed\/","title":{"rendered":"Neurologic Events After COVID-19 Vaccines Assessed"},"content":{"rendered":"
\n

MedPageToday<\/a> <\/p>\n\n\n\n

All patients hospitalized with new or relapsing neurologic events after SARS-CoV-2 vaccination at a New York tertiary hospital had one or more risk factors for their neurologic condition, a prospective study showed.<\/p>\n\n\n\n

The most prominent neurologic index events in these vaccinated patients were ischemic stroke (37.7%), encephalopathy (32.6%), seizure (15.9%), and intracranial hemorrhage (ICH; 9.4%), according to Kiran Thakur, MD, of Columbia University Irving Medical Center\/NewYork-Presbyterian Hospital in New York City, and co-authors. <\/p>\n\n\n\n

Of 3,830 individuals screened from December 2020 through June 2021 for COVID-19 vaccination status and neurologic conditions, 138 had a neurologic differential diagnosis and a COVID vaccine within 6 weeks of hospitalization, including 126 who received an mRNA vaccine. All 138 cases had at least one risk factor or evidence of a known potential cause of their neurologic event, Thakur and colleagues reported in Neurology: Clinical Practice<\/em>opens in a new tab or window<\/a>.<\/p>\n\n\n\n

Metabolic derangement was the most common etiology for vaccinated patients with seizures (53.3%) and encephalopathy (22.7%). Hypertension was the most significant risk factor for those with ischemic stroke (86.5%) and ICH (30.8%).<\/p>\n\n\n\n

“We were unable to determine a causal association between the new diagnosed neurologic condition and mRNA or adenovirus COVID-19 vaccination at our site,” the researchers stated.<\/p>\n\n\n\n

“Our comprehensive clinical review of these cases supports the safety of mRNA COVID-19 vaccines,” they added.<\/p>\n\n\n\n

Researchers and government agencies have warned of rare cases of cerebral venous sinus thrombosisopens in a new tab or window<\/a> (CVST) and Guillain-Barr\u00e9 syndromeopens in a new tab or window<\/a> (GBS) among people who received Johnson & Johnson’s COVID-19 adenovirus vector vaccine. Otherwise, U.S. vaccine safety surveillance systems have not detected unexpected safety concernsopens in a new tab or window<\/a> for clinically serious neurologic conditions after COVID-19 vaccinations, Thakur and colleagues noted.<\/p>\n<\/div><\/div>","protected":false},"excerpt":{"rendered":"

MedPageToday All patients hospitalized with new or relapsing neurologic events after SARS-CoV-2 vaccination at a New York tertiary hospital had one or more risk factors for their neurologic condition, a prospective study showed. The most prominent neurologic index events in these vaccinated patients were ischemic stroke (37.7%), encephalopathy (32.6%), seizure (15.9%), and intracranial hemorrhage (ICH; […]<\/p>\n","protected":false},"author":11,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":false,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[8],"tags":[],"class_list":["post-3691","post","type-post","status-publish","format-standard","hentry","category-vaccine-headlines"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/3691","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/comments?post=3691"}],"version-history":[{"count":1,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/3691\/revisions"}],"predecessor-version":[{"id":3692,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/3691\/revisions\/3692"}],"wp:attachment":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/media?parent=3691"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/categories?post=3691"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/tags?post=3691"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}